US 8080532
Compositions and methods for inhibiting expression of Huntingtin gene
granted A61PA61P25/00A61P25/14
Quick answer
US patent 8080532 (Compositions and methods for inhibiting expression of Huntingtin gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P25/00, A61P25/14